Evidence map›Paper›PMID 35808502›Full record

ArticleSensors (Basel, Switzerland)2022

Development and Validation of a Multimodal-Based Prognosis and Intervention Prediction Model for COVID-19 Patients in a Multicenter Cohort.

Jeong Hoon Lee, Jong Seok Ahn, Myung Jin Chung, Yeon Joo Jeong, Jin Hwan Kim, Jae Kwang Lim, Jin Young Kim, Young Jae Kim, Jong Eun Lee, Eun Young Kim

Abstract readMulticenter Study
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Artificial intelligence in respiratory care.Frontiers in digital health · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jeong Hoon LeeLunit Inc., 27, Teheran-ro 2-gil, Gangnam-gu, Seoul 06241, Korea.ORCID 0000-0002-1789-8270
Jong Seok AhnLunit Inc., 27, Teheran-ro 2-gil, Gangnam-gu, Seoul 06241, Korea.ORCID 0000-0003-1189-5981
Myung Jin ChungDepartment of Radiology and Medical AI Research Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Yeon Joo JeongDepartment of Radiology, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan 49241, Korea.
Jin Hwan KimDepartment of Radiology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon 35015, Korea.
Jae Kwang LimDepartment of Radiology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Korea.
Jin Young KimDepartment of Radiology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu 42601, Korea.
Young Jae KimDepartment of Biomedical Engineering, Gachon University College of Medicine, Incheon 21565, Korea.
Jong Eun LeeDepartment of Radiology, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 61469, Korea.ORCID 0000-0002-8754-6801
Eun Young KimDepartment of Radiology, Gil Medical Center, Gachon University College of Medicine, Namdong-daero 774 beon-gil, Namdong-gu, Incheon 21565, Korea.

Funding

The information and Communications Promotion Fund (ICT promotion fund) through the National IT industry Promotion Agency (NIPA), funded by the Ministry of Science and ICD (MSIT), Republic of Korea. NA
6 · The paper itself

Abstract

The ability to accurately predict the prognosis and intervention requirements for treating highly infectious diseases, such as COVID-19, can greatly support the effective management of patients, especially in resource-limited settings. The aim of the study is to develop and validate a multimodal artificial intelligence (AI) system using clinical findings, laboratory data and AI-interpreted features of chest X-rays (CXRs), and to predict the prognosis and the required interventions for patients diagnosed with COVID-19, using multi-center data. In total, 2282 real-time reverse transcriptase polymerase chain reaction-confirmed COVID-19 patients’ initial clinical findings, laboratory data and CXRs were retrospectively collected from 13 medical centers in South Korea, between January 2020 and June 2021. The prognostic outcomes collected included intensive care unit (ICU) admission and in-hospital mortality. Intervention outcomes included the use of oxygen (O2) supplementation, mechanical ventilation and extracorporeal membrane oxygenation (ECMO). A deep learning algorithm detecting 10 common CXR abnormalities (DLAD-10) was used to infer the initial CXR taken. A random forest model with a quantile classifier was used to predict the prognostic and intervention outcomes, using multimodal data. The area under the receiver operating curve (AUROC) values for the single-modal model, using clinical findings, laboratory data and the outputs from DLAD-10, were 0.742 (95% confidence interval [CI], 0.696−0.788), 0.794 (0.745−0.843) and 0.770 (0.724−0.815), respectively. The AUROC of the combined model, using clinical findings, laboratory data and DLAD-10 outputs, was significantly higher at 0.854 (0.820−0.889) than that of all other models (p < 0.001, using DeLong’s test). In the order of importance, age, dyspnea, consolidation and fever were significant clinical variables for prediction. The most predictive DLAD-10 output was consolidation. We have shown that a multimodal AI model can improve the performance of predicting both the prognosis and intervention in COVID-19 patients, and this could assist in effective treatment and subsequent resource management. Further, image feature extraction using an established AI engine with well-defined clinical outputs, and combining them with different modes of clinical data, could be a useful way of creating an understandable multimodal prediction model.

Indexed as

COVID-19Artificial IntelligenceHumansIntensive Care UnitsPrognosisRetrospective Studiesartificial intelligencechest radiographCOVID-19prognosis

Identifiers

PMID35808502
PMCPMC9269794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.